Real-time funding, M&A, exec moves & hiring — the signals that move deals
The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Aquestive Therapeutics, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Aquestive Therapeutics announced the departure of Chief Legal Officer and Chief Compliance Officer Lori J. Braender effective April 2, 2026, though she will remain as Corporate Secretary and provide transition services through May 7, 2026. This leadership change signals ongoing restructuring efforts at the company.
Key Takeaways
Lori J. Braender is stepping down from Chief Legal Officer and Chief Compliance Officer roles effective April 2, 2026
She will remain with the company through May 7, 2026 to provide transition services while receiving her current base salary
2 more takeaways
Related Filings (3)
3 more filings from Aquestive Therapeutics, Inc. in the last 90 days